RxDoctor Payments Data

Eric Dicicco, DO

Family Medicine · Downingtown, PANPI 1922010545

Payments from drug & device makers

$4,473in general payments, 2019–2025

Across 252 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$644
  • AbbVie$544
  • Pfizer$458
  • GSK$296
  • AstraZeneca$292
  • Lilly USA, LLC$266
  • plus $2K from 39 others

What the payments were for

  • Food & beverage$4,473100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,473 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$131,620
Medicare patients
450
Services billed
2,687

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$91,919
EliquisApixaban89$76,407
JardianceEmpagliflozin31$46,503
JanuviaSitagliptin Phosphate23$31,449
FarxigaDapagliflozin Propanediol29$27,159
XareltoRivaroxaban32$26,114
TrulicityDulaglutide12$22,612
MounjaroTirzepatide20$20,837
Xtampza ErOxycodone Myristate11$13,203
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$12,985
JanumetSitagliptin Phos/Metformin Hcl15$11,624
Amlodipine-ValsartanAmlodipine Besylate/Valsartan60$7,123
Rosuvastatin Calcium587$7,077
Atorvastatin Calcium521$6,103
Levothyroxine Sodium439$4,258

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$644$91,91989 claims
PfizerEliquis$458$76,40789 claims
Boehringer IngelheimJardiance$145$46,50331 claims
Lilly USA, LLCTrulicity, Mounjaro$266$43,45032 claims
MerckJanuvia, Janumet$71$43,07338 claims
AstraZenecaFarxiga$292$27,15929 claims
Johnson & JohnsonXarelto$41$26,11432 claims
GSKTrelegy Ellipta$296$12,98511 claims
AbbVieSynthroid$544$3,79862 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Downingtown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →